サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1555480

脳疾患モダリティ・ソフトウェア市場：製品タイプ別、患者タイプ別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Brain Disease Modalities and Software Market, By Product Type, By Patient Type, By Indication, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
脳疾患モダリティ・ソフトウェア市場：製品タイプ別、患者タイプ別、適応症別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

脳疾患モダリティ・ソフトウェアの市場規模は2023年に136億9,032万米ドルとなり、2024年から2032年にかけてCAGR5.90%で拡大

脳疾患モダリティ・ソフトウェア市場 - 市場力学

神経疾患の有病率の増加と、より安全で非侵襲的な画像診断装置への需要が市場の成長を促進すると予測されます。

世界人口の高齢化に伴い、アルツハイマー病、パーキンソン病、多発性硬化症、てんかんを含む神経疾患の有病率が顕著に増加しています。このような患者層の拡大により、高度な診断・治療アプローチの開発が必要とされています。Institute for Health Metrics and Evaluationの報告によると、2021年には、神経疾患は、病気、障害、早期死亡（障害調整生存年数で測定）により失われる健康寿命の4億4,300万年を占め、心血管疾患を上回る世界の疾病負担の主要な原因となっています。MRIやPETスキャンなどの非侵襲的画像診断技術は、侵襲的な方法に代わる安全な方法であり、合併症のリスクや患者の不快感を最小限に抑えることができます。さらに、高解像度MRI、機能的MRI（fMRI）、拡張PETスキャンなどの画像技術の進歩が、脳疾患モダリティ・ソフトウェア市場に機会をもたらしています。しかし、認知度やアクセシビリティが限定的であることが、市場の成長にとって課題となる可能性があります。

脳疾患モダリティ・ソフトウェア市場 - 主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024年～2032年）に約5.90％のCAGRで毎年成長すると推定されます。

製品タイプ別では、脳イメージングモダリティが2023年に最大市場シェアを示すと予測されています。

患者タイプ別では、2023年に小児科が主要タイプでした。

適応症別では、外傷性脳損傷（TBI）が2023年の主要タイプでした。

エンドユーザー別では、画像診断センターが2023年の主要タイプでした。

地域別では、北米が2023年の売上高でトップでした。

脳疾患モダリティ・ソフトウェア市場 - セグメンテーション分析：

世界の脳疾患モダリティ・ソフトウェア市場は、製品タイプ、患者タイプ、適応症、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品タイプによって2つに区分されます：脳分析ソフトウェアと脳画像モダリティです。脳画像モダリティは市場の大半のシェアを占めています。この分野の中で、脳画像モダリティは脳の構造と機能を包括的に理解する上で極めて重要です。

市場は患者タイプによって3つのグループに区分されます：成人、乳幼児、小児科です。小児科が市場の最大シェアを占めています。小児神経学では、幼い患者の脳疾患を効果的に診断・治療するために、特殊な画像モダリティ・ソフトウェアソリューションが不可欠です。

市場は適応症別に8つのカテゴリーに区分されます：外傷性脳損傷（TBI）、頭痛障害、てんかん、睡眠障害、パーキンソン病、脳卒中、ハンチントン病、認知症です。外傷性脳損傷（TBI）が市場で最大のシェアを占めています。TBIは、診断、モニタリング、リハビリを強化するために最先端の脳画像技術とソフトウェア・ソリューションが利用される重要な重点分野です。

市場はエンドユーザーによって、病院・診療所、外来手術センター、画像診断センターの3つに分類されます。このうち、画像診断センターが市場で支配的な地位を占めています。これらの施設では、様々な脳画像技術やソフトウェアアプリケーションを採用して、神経疾患の診断、モニタリング、管理を行っています。

脳疾患モダリティ・ソフトウェア市場 - 地理的洞察

同市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカを含む広範な地域にまたがっています。これらの地域は、事業活動に貢献している国に基づいてさらに分類されます。北米は、主に医療用画像処理における人工知能の統合が進み、技術的進歩が著しいことから、主要地域となっています。特に米国とカナダは、AIと機械学習を医療画像と診断ソフトウェアに組み込む最前線にあります。これらの技術革新により、画像解析の強化、診断精度の向上、ワークフローの最適化が促進され、北米企業に競争優位性をもたらしています。2020年、米国放射線学会（ACR）は、臨床現場における会員のAI活用を評価するために調査を行い、1,427件の回答を受け取り、その結果、放射線科医の33.5％が診療にAIを活用していることが明らかになりました。欧州は、高いヘルスケア支出と導入率に起因する市場成長で2番目に大きい地域にランクされています。

脳疾患モダリティ・ソフトウェア市場 - 競合情勢：

脳疾患モダリティ・ソフトウェア市場は高いレベルの競争を示しており、多数の市場参入企業が技術革新、戦略的提携、技術の進歩を通じて市場シェアの確保に努めています。各社は、最先端の画像診断モダリティ・ソフトウェアソリューションを開発するため、研究開発に多額の投資を行っています。診断精度の向上と業務効率の改善に極めて重要な人工知能と機械学習が重視されています。大手企業は、技術力を拡大し、脳疾患の診断と治療における新たなイノベーションにアクセスするために、中小企業や新興企業を買収しています。さらに、企業は新しい地域や新興市場に進出することで市場での存在感を高め、洗練された脳疾患診断ツールに対する需要の増加を活用しています。

目次

第1章 脳疾患モダリティ・ソフトウェア市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 脳疾患モダリティ・ソフトウェアの主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 脳疾患モダリティ・ソフトウェア産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 脳疾患モダリティ・ソフトウェア市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 脳疾患モダリティ・ソフトウェア市場情勢

  • 脳疾患モダリティ・ソフトウェア市場シェア分析、2023年
  • 内訳データ：主要メーカー別
    • 既存企業の分析
    • 新興企業の分析

第7章 脳疾患モダリティ・ソフトウェア市場 - 製品タイプ別

  • 概要
    • セグメントシェア分析：製品タイプ別
    • 脳分析ソフトウェア
    • 脳画像診断法
      • CT装置
      • MRI装置
      • PETデバイス
      • PET-CT
      • PET-MRI

第8章 脳疾患モダリティ・ソフトウェア市場 - 患者タイプ別

  • 概要
    • セグメントシェア分析：患者タイプ別
    • 大人
    • 乳児
    • 小児科

第9章 脳疾患モダリティ・ソフトウェア市場 - 適応症別

  • 概要
    • セグメントシェア分析：適応症別
    • 外傷性脳損傷（TBI）
    • 頭痛障害
    • てんかん
    • 睡眠障害
    • パーキンソン病
    • 脳卒中
    • ハンチントン病
    • 痴呆

第10章 脳疾患モダリティ・ソフトウェア市場 - エンドユーザー別

  • 概要
    • セグメントシェア分析：エンドユーザー別
    • 病院・診療所
    • 外来手術センター
    • 画像診断センター

第11章 脳疾患モダリティ・ソフトウェア市場 - 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析 - 脳疾患モダリティ・ソフトウェア業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Quantib
    • Brainomix
    • Qure.ai
    • GE Company
    • Imaging Biometrics, LLC
    • United Imaging Healthcare Co. Ltd.
    • Siemens
    • Healthineers AG
    • KONINKLIJKE PHILIPS ELECTRONICS NV
    • Canon Inc.
    • VUNO Inc.
    • Aspect Imaging
    • IXICO
    • QMENTA
    • Cortechs.ai
    • AI Analysis, Inc.
    • FUJIFILM Holdings Corporation
    • その他

第13章 アナリストの全方位展望

目次
Product Code: ANV3594

REPORT HIGHLIGHT

Brain Disease Modalities and Software Market size was valued at USD 13,690.32 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

The diagnosis of brain diseases through the use of multiple imaging modalities has demonstrated enhanced effectiveness when compared to the application of a single modality. However, the availability of multi-modal data in clinical practice is often limited due to financial constraints or the associated risks of radiation exposure. The modalities and software utilized for brain disease encompass a diverse range of technologies and applications aimed at diagnosing, monitoring, and treating various neurological disorders. These tools are vital in contemporary neurology, offering extensive diagnostic capabilities, supporting research initiatives, and improving treatment and rehabilitation results for patients suffering from neurological conditions.

Brain Disease Modalities and Software Market- Market Dynamics

The increasing prevalence of neurological disorders and demands for safer and non-invasive imaging devices is expected to drive the growth of the market

With the aging of the global population, there is a notable rise in the prevalence of neurological disorders, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and epilepsy. This expanding demographic of patients necessitates the development of sophisticated diagnostic and therapeutic approaches. In 2021, neurological disorders accounted for 443 million years of healthy life lost due to illness, disability, and premature mortality (measured in disability-adjusted life years), positioning them as the leading cause of the global disease burden, surpassing cardiovascular diseases, as reported by the Institute for Health Metrics and Evaluation. Non-invasive imaging techniques, such as MRI and PET scans, present a safer alternative to invasive methods, minimizing the risk of complications and discomfort for patients, which in turn promotes their wider acceptance. Additionally, advancements in imaging technologies, including high-resolution MRI, functional MRI (fMRI), and enhanced PET scans, create opportunities for the Brain Disease Modalities and Software market. However, limited awareness and accessibility may pose challenges to the market's growth.

Brain Disease Modalities and Software Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on product type segmentation, Brain Imaging Modalities was predicted to show maximum market share in the year 2023

Based on Patient Type segmentation, Pediatrics was the leading type in 2023

Based on Indication segmentation, Traumatic Brain Injury (TBI) was the leading type in 2023

Based on End-User segmentation, Diagnostic Imaging Centers were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Brain Disease Modalities and Software Market- Segmentation Analysis:

The Global Brain Disease Modalities and Software Market is segmented based on Product Type, Patient Type, Indication, End-User, and Region.

The market is segmented into two categories according to product type: Brain Analysis Software and Brain Imaging Modalities. Brain Imaging Modalities holds the majority share in the market. Within this sector, brain imaging modalities are crucial in offering a comprehensive understanding of brain structure and function.

The market is segmented into three groups according to Patient Type: Adults, Infants, and Pediatrics. Pediatrics holds the largest share of the market. Specialized imaging modalities and software solutions are essential in pediatric neurology to effectively diagnose and treat brain diseases in young patients.

The market is segmented into eight categories according to Indication: Traumatic Brain Injury (TBI), Headache disorders, Epilepsy, Sleep disorders, Parkinson's disease, Stroke, Huntington's disease, and Dementia. Traumatic Brain Injury (TBI) holds the largest share in the market. TBI is a significant focus area where cutting-edge brain imaging technologies and software solutions are utilized to enhance diagnosis, monitoring, and rehabilitation.

The market is segmented into three distinct categories according to the End-User: Hospitals and Clinics, Ambulatory Surgery Centers, and Diagnostic Imaging Centers. Among these, Diagnostic Imaging Centers hold a dominant position in the market. These facilities employ various brain imaging techniques and software applications to diagnose, monitor, and manage neurological disorders.

Brain Disease Modalities and Software Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These areas are further categorized based on the countries contributing to business activities. North America is the leading region, primarily due to the increasing integration of artificial intelligence in medical imaging and significant technological advancements. Specifically, the United States and Canada are at the forefront of incorporating AI and machine learning into medical imaging and diagnostic software. These innovations facilitate enhanced image analysis, boost diagnostic precision, and optimize workflows, thereby providing North American firms with a competitive advantage. In 2020, the American College of Radiology (ACR) was surveyed to assess the utilization of AI among its members in clinical settings, receiving 1,427 responses, which revealed that 33.5% of radiologists were employing AI in their practices. Europe ranks as the second-largest region for market growth, attributed to high healthcare expenditure and adoption rates.

Brain Disease Modalities and Software Market- Competitive Landscape:

The Brain Disease Modalities and Software Market exhibits a high level of competition, with a multitude of participants striving to secure market share through innovation, strategic alliances, and advancements in technology. Companies are making substantial investments in research and development to create state-of-the-art imaging modalities and software solutions. Significant emphasis is placed on artificial intelligence and machine learning, which are pivotal in improving diagnostic precision and operational efficiency. Leading firms are acquiring smaller enterprises and startups to broaden their technological capabilities and access novel innovations in the diagnosis and treatment of brain diseases. Additionally, organizations are enhancing their market presence by penetrating new geographic territories and emerging markets, thereby leveraging the increasing demand for sophisticated brain disease diagnostic tools.

Recent Developments:

On May 6, 2022, during the International Society for Magnetic Resonance in Medicine (ISMRM) 2022 Annual Meeting, GE Healthcare announced the further advancement of its innovative deep learning image reconstruction solution, AIR Recon DL, to its extensive customer base through both upgrades and new purchases across its MR product portfolio.

Royal Philips, a prominent global entity in health technology, in collaboration with Synthetic MR, a company specializing in magnetic resonance imaging (MRI) software solutions based in Linkoping, Sweden, has today unveiled Smart Quant Neuro 3D. This innovative development represents a significant progression in providing objective decision support for the diagnosis and therapeutic evaluation of neurological conditions such as multiple sclerosis (MS), traumatic brain injury (TBI), and dementia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Quantib
  • Brainomix
  • Qure.ai
  • GE Company
  • Imaging Biometrics, LLC
  • United Imaging Healthcare Co. Ltd.
  • Siemens
  • Healthineers AG
  • KONINKLIJKE PHILIPS ELECTRONICS NV
  • Canon Inc.
  • VUNO Inc.
  • Aspect Imaging
  • IXICO
  • QMENTA
  • Cortechs.ai
  • A.I. Analysis, Inc.
  • FUJIFILM Holdings Corporation
  • Others

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Brain Analysis Software
  • Brain Imaging Modalities
  • CT Devices
  • MRI Devices
  • PET Devices
  • PET-CT
  • PET-MRI

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY PATIENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Adults
  • Infants
  • Pediatrics

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Traumatic Brain Injury (TBI)
  • Headache disorders
  • Epilepsy
  • Sleep disorders
  • Parkinson's disease
  • Stroke
  • Huntington's disease
  • Dementia

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Ambulatory Surgery Centers
  • Diagnostic Imaging Centers

GLOBAL BRAIN DISEASE MODALITIES AND SOFTWARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Brain Disease Modalities and Software Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Brain Disease Modalities and Software Market Snippet by Product Type
    • 2.1.2. Brain Disease Modalities and Software Market Snippet by Patient Type
    • 2.1.3. Brain Disease Modalities and Software Market Snippet by Indication
    • 2.1.4. Brain Disease Modalities and Software Market Snippet by End-User
    • 2.1.5. Brain Disease Modalities and Software Market Snippet by Country
    • 2.1.6. Brain Disease Modalities and Software Market Snippet by Region
  • 2.2. Competitive Insights

3. Brain Disease Modalities and Software Key Market Trends

  • 3.1. Brain Disease Modalities and Software Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Brain Disease Modalities and Software Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Brain Disease Modalities and Software Market Opportunities
  • 3.4. Brain Disease Modalities and Software Market Future Trends

4. Brain Disease Modalities and Software Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Brain Disease Modalities and Software Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Brain Disease Modalities and Software Market Landscape

  • 6.1. Brain Disease Modalities and Software Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Brain Disease Modalities and Software Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Brain Analysis Software
    • 7.1.3. Brain Imaging Modalities
      • 7.1.3.1. CT Devices
      • 7.1.3.2. MRI Devices
      • 7.1.3.3. PET Devices
      • 7.1.3.4. PET-CT
      • 7.1.3.5. PET-MRI

8. Brain Disease Modalities and Software Market - By Patient Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Patient Type, 2023 & 2032 (%)
    • 8.1.2. Adults
    • 8.1.3. Infants
    • 8.1.4. Paediatrics

9. Brain Disease Modalities and Software Market - By Indication

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 9.1.2. Traumatic Brain Injury (TBI)
    • 9.1.3. Headache disorders
    • 9.1.4. Epilepsy
    • 9.1.5. Sleep disorders
    • 9.1.6. Parkinson's disease
    • 9.1.7. Stroke
    • 9.1.8. Huntington's disease
    • 9.1.9. Dementia

10. Brain Disease Modalities and Software Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals and Clinics
    • 10.1.3. Ambulatory Surgery Centers
    • 10.1.4. Diagnostic Imaging Centers

11. Brain Disease Modalities and Software Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Brain Disease Modalities and Software Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Brain Disease Modalities and Software Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Brain Disease Modalities and Software Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Brain Disease Modalities and Software Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Brain Disease Modalities and Software Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Patient Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Brain Disease Modalities and Software Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Quantib
    • 12.2.2. Brainomix
    • 12.2.3. Qure.ai
    • 12.2.4. GE Company
    • 12.2.5. Imaging Biometrics, LLC
    • 12.2.6. United Imaging Healthcare Co. Ltd.
    • 12.2.7. Siemens
    • 12.2.8. Healthineers AG
    • 12.2.9. KONINKLIJKE PHILIPS ELECTRONICS NV
    • 12.2.10. Canon Inc.
    • 12.2.11. VUNO Inc.
    • 12.2.12. Aspect Imaging
    • 12.2.13. IXICO
    • 12.2.14. QMENTA
    • 12.2.15. Cortechs.ai
    • 12.2.16. A.I. Analysis, Inc.
    • 12.2.17. FUJIFILM Holdings Corporation
    • 12.2.18. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us